2021 annual financial data
Protara Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -47.49M USD and net income was -47.25M USD.
Operating cash flow was -34.5M USD.
Get free Protara Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -47.49M USD
- Net income
- -47.25M USD
- Operating cash flow
- -34.5M USD